Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Kidney Cancer|Lymphoma|Melanoma|Multiple Myeloma|Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: recombinant interferon alpha-1b|DRUG: IFN
Sponsor: The Cleveland Clinic
Collaborators: National Cancer Institute (NCI)